- Exenatide, sold
under the
brand name
Byetta among others, is a
medication used to
treat type 2 diabetes. It is used
together with diet, exercise, and potentially...
-
other diseases.
Amylin produced three drugs:
Symlin (pramlintide acetate),
Byetta (exenatide) and
Bydureon (exenatide
extended release). In 1987,
Amylin Pharmaceuticals...
- Food and Drug
Administration approved the drug
exenatide (marketed as
Byetta) for the
management of type 2 diabetes. It is a
synthetic modification of...
-
substance is now
synthesized for use in the anti-diabetes drug
exenatide (
Byetta).
Another toxin from Gila
monster saliva has been
studied for use as an...
-
primarily selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine.
Byetta, a type II
diabetes drug, will
cause moderate nausea and loss of appetite...
- one of
these substances is now used in the anti-diabetes drug
exenatide (
Byetta), a glucagon-like peptide-1 (GLP-1)
receptor agonist like
semiglutide (Ozempic)...
-
Bydureon (exenatide extended-release) –
marketed by BMS only in some
countries Byetta (exenatide) –
marketed by BMS only in some countries, such as
Russian Federation...
-
triple agonist In
clinical trials 24
percent in a
Phase II
trial Exenatide Byetta GLP-1
receptor agonist Approved for type 2
diabetes 2.5
kilograms (5.5 lb)...
- cost-effective for
pediatric obesity in the U.S.
exenatide (brand
names Byetta and Bydureon,
manufactured by AstraZeneca),
approved in 2005/2012[citation...
-
butoxylate (INN)
butriptyline (INN)
butropium bromide (INN)
butynamine (INN)
Buzepide metiodide (INN) BW524W91
Byclomine Bydramine Bydureon Byetta Byooviz...
